David Rosenbaum
Managing Director of Rosenbaum Group, United Kingdom
David Rosenbaum has a decade of experience in the conduct of Clinical Trials with practical monitoring and auditing experience in 15 countries from the Europe region.
He holds a Master's Degree in Regulations and Standards in Medicine. Currently, he is Managing Director of Rosenbaum Group a hybrid ???????? ???????? ???????? ???????? providing consultancy and CRO services to small and mid-sized biotech companies. At the moment the main focus of Rosenbaum Group is on the therapeutic indications of CNS, COVID19 Trials, stem cell therapies, and decentralized clinical trials.
CONTACT
For more information about your participation, please contact us at info@clinicaltrialsymposium.com
For additional information regarding partnership, sponsors & exhibitors and media, please contact our
marketing and communication department at anca.bejenaru@avantyo.com